• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从帕金森病的动态氟代脱氧葡萄糖正电子发射断层扫描研究中确定区域速率常数。

Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.

作者信息

Piert M, Koeppe R A, Giordani B, Minoshima S, Kuhl D E

机构信息

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109, USA.

出版信息

J Nucl Med. 1996 Jul;37(7):1115-22.

PMID:8965180
Abstract

UNLABELLED

Dynamic [18F]fluorodeoxyglucose (FDG) PET was used in Parkinson's disease patients and normal controls to determine kinetic rate constants for FDG. The goal was to assess whether the metabolic decreases observed in Parkinson's disease are associated with transport or phosphorylation processes or both.

METHODS

Fluorine-18-FDG was administered to 18 Parkinson's disease and 15 normal control subjects. Dynamic PET scanning was performed for 1 h and rate constants were obtained by nonlinear, least-squares analysis. Regional glucose metabolic rate was calculated from the individually fitted rate constants and by two standard static scan analyses.

RESULTS

Global CMRglu was decreased in Parkinson's disease (mean reduction 22%), reaching statistical significance in all regions investigated. K1 was significantly reduced in parietal cortex, temporal cortex and striatum while k3 was significantly reduced only in parietal cortex. The rate constant k2 was unchanged.

CONCLUSION

K1, k3 and CMRglu all demonstrated greater deficits across the brain with progression of disease and development of dementia, particularly in the parietal an occipital cortex. This suggested that the metabolic disturbance may be a global dysfunction throughout the brain. Because altered rate constants are specifically taken into account, dynamic measurements has shown to provide higher sensitivity for detecting diminished glucose utilization in Parkinson's disease than static approaches.

摘要

未标注

对帕金森病患者和正常对照者使用动态[18F]氟脱氧葡萄糖(FDG)PET来确定FDG的动力学速率常数。目的是评估在帕金森病中观察到的代谢降低是否与转运或磷酸化过程或两者都有关。

方法

对18例帕金森病患者和15名正常对照者给予氟-18-FDG。进行1小时的动态PET扫描,并通过非线性最小二乘法分析获得速率常数。根据个体拟合的速率常数并通过两种标准静态扫描分析计算区域葡萄糖代谢率。

结果

帕金森病患者的整体葡萄糖代谢率(CMRglu)降低(平均降低22%),在所有研究区域均达到统计学显著性。顶叶皮质、颞叶皮质和纹状体中的K1显著降低,而k3仅在顶叶皮质中显著降低。速率常数k2未改变。

结论

随着疾病进展和痴呆的发展,K1、k3和CMRglu在全脑均表现出更大的缺陷,尤其是在顶叶和枕叶皮质。这表明代谢紊乱可能是全脑的整体功能障碍。由于特别考虑了改变的速率常数,动态测量已显示出比静态方法在检测帕金森病中葡萄糖利用减少方面具有更高的灵敏度。

相似文献

1
Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.从帕金森病的动态氟代脱氧葡萄糖正电子发射断层扫描研究中确定区域速率常数。
J Nucl Med. 1996 Jul;37(7):1115-22.
2
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.通过动态氟代脱氧葡萄糖正电子发射断层扫描术确定阿尔茨海默病中葡萄糖转运和磷酸化的减少。
J Nucl Med. 1996 Feb;37(2):201-8.
3
Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.通过[18F]-2-氟-2-脱氧-D-葡萄糖的动态正电子发射断层扫描测定正常人类志愿者的区域动力学常数和脑葡萄糖代谢率。
J Cereb Blood Flow Metab. 1984 Jun;4(2):212-23. doi: 10.1038/jcbfm.1984.30.
4
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].[18F-氟脱氧葡萄糖正电子发射断层扫描在帕金森病中的应用]
Nihon Rinsho. 1997 Jan;55(1):222-6.
5
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.帕金森病和阿尔茨海默病中与痴呆严重程度相匹配的脑代谢差异。
J Nucl Med. 1997 May;38(5):797-802.
6
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.帕金森病的代谢解剖学:互补性的[18F]氟脱氧葡萄糖和[18F]氟多巴正电子发射断层扫描研究。
Mov Disord. 1990;5(3):203-13. doi: 10.1002/mds.870050304.
7
Diminished glucose transport in Alzheimer's disease: dynamic PET studies.阿尔茨海默病中葡萄糖转运减少:动态PET研究
J Cereb Blood Flow Metab. 1991 Mar;11(2):323-30. doi: 10.1038/jcbfm.1991.65.
8
Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.使用氟代脱氧葡萄糖(FDG)和正电子发射断层扫描(PET)对葡萄糖磷酸化进行的测量不会因FDG-6-磷酸的去磷酸化而降低。
J Nucl Med. 1991 Apr;32(4):692-8.
9
Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.从动态[18F]氟代脱氧葡萄糖/PET数据中选择固定的去磷酸化速率对速率常数和rCMRGlu估计的影响。
J Nucl Med. 1989 Sep;30(9):1483-8.
10
Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.神经胶质瘤中独立的铊-201蓄积与氟-18-氟脱氧葡萄糖代谢
J Nucl Med. 1996 Mar;37(3):457-62.

引用本文的文献

1
Longitudinal Cerebral Perfusion Changes in Parkinson's Disease with Subjective Cognitive Impairment.帕金森病伴主观认知障碍患者的脑纵向灌注变化
Dement Neurocogn Disord. 2016 Dec;15(4):147-152. doi: 10.12779/dnd.2016.15.4.147. Epub 2016 Dec 31.
2
Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.低脑葡萄糖代谢:血管性帕金森综合征和帕金森病严重程度的潜在预测指标
Aging Dis. 2015 Nov 17;6(6):426-36. doi: 10.14336/AD.2015.0204. eCollection 2015 Nov.
3
Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
帕金森病中的线粒体功能障碍与α-突触核蛋白突触病理学:谁先出现?
Parkinsons Dis. 2015;2015:108029. doi: 10.1155/2015/108029. Epub 2015 Mar 31.
4
[Differential diagnostics of Parkinson's disease with nuclear medicine procedures].[帕金森病的核医学检查鉴别诊断]
Nervenarzt. 2014 Jun;85(6):680-9. doi: 10.1007/s00115-013-3995-1.
5
Simultaneous measurement of glucose blood-brain transport constants and metabolic rate in rat brain using in-vivo 1H MRS.使用体内 1H MRS 同时测量大鼠脑内葡萄糖的血脑转运常数和代谢率。
J Cereb Blood Flow Metab. 2012 Sep;32(9):1778-87. doi: 10.1038/jcbfm.2012.82. Epub 2012 Jun 20.
6
Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons.帕金森猴的初级运动皮层:对锥体束型神经元自发性活动的不同影响。
Cereb Cortex. 2011 Jun;21(6):1362-78. doi: 10.1093/cercor/bhq217. Epub 2010 Nov 2.
7
PET studies of cerebral metabolism in Parkinson disease.正电子发射断层扫描研究帕金森病的脑代谢。
J Bioenerg Biomembr. 2009 Dec;41(6):505-8. doi: 10.1007/s10863-009-9251-5.
8
Cerebral mitochondrial metabolism in early Parkinson's disease.早期帕金森病中的脑线粒体代谢
J Cereb Blood Flow Metab. 2008 Oct;28(10):1754-60. doi: 10.1038/jcbfm.2008.63. Epub 2008 Jun 25.
9
A whole-brain analysis in de novo Parkinson disease.新发帕金森病的全脑分析。
AJNR Am J Neuroradiol. 2008 Apr;29(4):674-80. doi: 10.3174/ajnr.A0900. Epub 2008 Jan 9.
10
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study.帕金森病临床非痴呆患者皮质功能障碍的证据:一项质子磁共振波谱研究。
J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):20-6. doi: 10.1136/jnnp.67.1.20.